Skip to content
Halcinonide
Halog (halcinonide) is a small molecule pharmaceutical. Halcinonide was first approved as Halog on 1982-01-01. It is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, and leg dermatoses amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Halog (generic drugs available since 2019-08-12)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Halcinonide
Tradename
Company
Number
Date
Products
HALOGSun Pharmaceutical IndustriesN-017556 RX1982-01-01
1 products, RLD, RS
HALOGSun Pharmaceutical IndustriesN-017823 RX1982-01-01
1 products, RLD, RS
HALOGSun Pharmaceutical IndustriesN-017824 RX1982-01-01
1 products, RLD, RS
Show 3 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
halcinonideANDA2021-09-17
halogNew Drug Application2020-03-26
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
facial dermatoses—D005148—
foot dermatoses—D005533—
hand dermatoses—D006229—
inflammationMP_0001845D007249—
leg dermatoses—D007868—
scalp dermatoses—D012536—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D07: Corticosteroids, dermatological preparations
— D07A: Corticosteroid dermatological preparations, plain
— D07AD: Corticosteroids, very potent (group iv)
— D07AD02: Halcinonide
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHALCINONIDE
INNhalcinonide
Description
Halcinonide is an organic molecular entity. It has a role as a SMO receptor agonist.
Classification
Small molecule
Drug classtopical steroids (acetal derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1
Identifiers
PDB—
CAS-ID3093-35-4
RxCUI5084
ChEMBL IDCHEMBL1200845
ChEBI ID—
PubChem CID443943
DrugBankDB06786
UNII IDSI86V6QNEG (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 164 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
7 adverse events reported
View more details